ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹4,157 Cr | ₹3,754 Cr | ₹3,528 Cr | ₹3,220 Cr | ₹2,834 Cr |
What is the latest Total Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹4,157 Cr |
| Mar2025 | ₹3,754 Cr |
| Mar2024 | ₹3,528 Cr |
| Mar2023 | ₹3,220 Cr |
| Mar2022 | ₹2,834 Cr |
How is Total Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,157 Cr | 10.75 | |
| Mar2025 | ₹3,754 Cr | 6.39 | |
| Mar2024 | ₹3,528 Cr | 9.55 | |
| Mar2023 | ₹3,220 Cr | 13.65 | |
| Mar2022 | ₹2,834 Cr | - | |
Compare Total Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,699.6 Cr | -2.2% | -1% | 36% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -2.2% |
-1% |
36% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses